Formulation Development Solutions

  1. MaxPeak Premier For Glycan Analysis 7/6/2022

    MaxPeak™ Premier Columns utilize MaxPeak high performance surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.

  2. Controlled Substances

    Cambrex holds US Drug Enforcement Agency (DEA) licenses for process research, development, manufacturing, and importation of Schedule I to IV controlled substances.

  3. Custom GMP-Grade Oligos 6/30/2026

    See how controlled manufacturing, traceability, scalable capacity, and built-in quality checks can reduce risk and support reliable assay workflows, as well as what to look for in a raw material partner.

  4. Small Molecule Drug Substance 6/17/2026

    With extensive experience in handling challenging chemistries and complex synthetic processes, we deliver tailored solutions designed to support successful progression from preclinical studies to market.

  5. ADC And Bioconjugation Center Of Excellence 3/25/2024

    Learn about a manufacturing site with over 35 years of expertise in bioconjugation, APIs, excipients, and adjuvants manufacturing that helps clients accelerate drug development programs worldwide.

  6. Chip-R1™ Basic Research Kit 10/15/2024

    Discover how you can improve precision in ADME and toxicology applications with a low-drug absorption profile.

  7. A Comprehensive Method Development Experience

    Our combined method development experience ensures that client methods are robust, effective, flexible, innovative and allow true stability indication.

  8. Duodenum Intestine Bio-Kit 2/13/2024

    The human small intestine plays a critical role in human health and gastrointestinal disease but remains challenging to study. Learn about a duodenum intestine model that offers a viable solution.

  9. Accelerate Molecules Through Development With Translational Pharmaceutics® 3/17/2025

    By leveraging real-time data and operational efficiency, we accelerate timelines — manufacturing and releasing drug products in under seven days and reducing development cycles by up to 12 months.

  10. Multi-Mode Microplate Reader 7/24/2025

    Unlock precision and flexibility with an affordable, high-performance solution for absorbance, fluorescence, and luminescence assays, with advanced upgrades for live-cell analysis.